col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Frontiers Media SA: Frontiers in Immunology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―21 Monocytes and Macrophages in COVID-19 Rainer Knoll, Joachim L. Schultze, Jonas Schulte-Schrepping
2 [GO] 2021―Jul―20 Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study Danrong Shi, Tianhao Weng, Jie Wu, Chunyan Dai, Rui Luo, Keda Chen, et al. (+13)
3 [GO] 2021―Jul―19 Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level Hannah C. Copley, Loren Gragert, Andrew R. Leach, Vasilis Kosmoliaptsis
4 [GO] 2021―Jul―15 Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19 Nathalie Acevedo, Jose Miguel Escamilla-Gil, Héctor Espinoza, Ronald Regino, Jonathan Ramírez, Lucila Florez de Arco, et al. (+3)
5 [GO] 2021―Jul―15 Comprehensive Profiling of Inflammatory Factors Revealed That Growth Differentiation Factor-15 Is an Indicator of Disease Severity in COVID-19 Patients Xiangyun Teng, Jiaqi Zhang, Yaling Shi, Yuntao Liu, Yanqing Yang, Jinyong He, et al. (+9)
6 [GO] 2021―Jul―12 Erratum: Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease
7 [GO] 2021―Jul―12 Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology Sophie Steiner, Tatjana Schwarz, Victor M. Corman, Franziska Sotzny, Sandra Bauer, Christian Drosten, et al. (+3)
8 [GO] 2021―Jul―12 Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine Jules Russick, Pierre-Emmanuel Foy, Nathalie Josseaume, Maxime Meylan, Nadine Ben Hamouda, Amos Kirilovsky, et al. (+12)
9 [GO] 2021―Jul―12 SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants Daniel Martínez-Flores, Jesús Zepeda-Cervantes, Adolfo Cruz-Reséndiz, Sergio Aguirre-Sampieri, Alicia Sampieri, Luis Vaca
10 [GO] 2021―Jul―09 Comparative Characterization and Risk Stratification of Asymptomatic and Presymptomatic Patients With COVID-19 Lei Shi, Rong Ding, Tingting Zhang, Wei Wu, Ziyu Wang, Xiuzhi Jia, et al. (+17)
11 [GO] 2021―Jul―08 Exploring the Immunopathogenesis of Pregnancy With COVID-19 at the Vaccination Era Dan Lv, Jing Peng, Rui Long, Xingguang Lin, Renjie Wang, Di Wu, et al. (+4)
12 [GO] 2021―Jul―08 The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current Evidence Mengyuan Zhang, Xiaoyin Bai, Wei Cao, Junyi Ji, Luo Wang, Yang Yang, Hong Yang
13 [GO] 2021―Jul―08 Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis Lakhveer Singh, Sakshi Bajaj, Manoj Gadewar, Nitin Verma, Mohd Nazam Ansari, Abdulaziz S. Saeedan, et al. (+2)
14 [GO] 2021―Jul―08 The Spike of SARS-CoV-2: Uniqueness and Applications Ranjith Kumavath, Debmalya Barh, Bruno Silva Andrade, Madangchanok Imchen, Flavia Figueira Aburjaile, Athira Ch, et al. (+7)
15 [GO] 2021―Jul―07 From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang-Soo Lee
16 [GO] 2021―Jul―07 SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns Natalia Redondo, Sara Zaldívar-López, Juan J. Garrido, Maria Montoya
17 [GO] 2021―Jul―07 Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1 Jing Yang, Edith A. Perez, Changchun Hou, Pin Zhang, Michelle Van Scoyk, Robert A. Winn, et al. (+2)
18 [GO] 2021―Jul―07 ROS/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control - a Complex Early Trait (‘CoV-MAC-TED’) for Combating SARS-CoV-2-Induced Cell Reprogramming José Hélio Costa, Gunasekaran Mohanapriya, Revuru Bharadwaj, Carlos Noceda, Karine Leitão Lima Thiers, Shahid Aziz, et al. (+10)
19 [GO] 2021―Jul―05 Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins Youssif M. Ali, Matteo Ferrari, Nicholas J. Lynch, Sadam Yaseen, Thomas Dudler, Sasha Gragerov, et al. (+3)
20 [GO] 2021―Jul―05 Hypopharyngeal Ulcers in COVID-19: Histopathological and Virological Analyses - A Case Report Andrea Porzionato, Elena Stocco, Aron Emmi, Martina Contran, Veronica Macchi, Silvia Riccetti, et al. (+3)
21 [GO] 2021―Jul―05 Commentary: Why Haven’t We Found an Effective Treatment for COVID-19? Josef Brzoska, Harald von Eick, Manfred Hündgen
22 [GO] 2021―Jul―01 AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19 Anastasia Meshcheryakova, Peter Pietschmann, Philip Zimmermann, Igor B. Rogozin, Diana Mechtcheriakova
23 [GO] 2021―Jul―01 Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient Changchun Lai, Xinglong Liu, Qihong Yan, Hualiang Lv, Lei Zhou, Longbo Hu, et al. (+19)
24 [GO] 2021―Jul―01 Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality Bandar Alosaimi, Ayman Mubarak, Maaweya E. Hamed, Abdullah Z. Almutairi, Ahmed A. Alrashed, Abdullah AlJuryyan, et al. (+3)
25 [GO] 2021―Jun―30 Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19 Rakhee K. Ramakrishnan, Tarek Kashour, Qutayba Hamid, Rabih Halwani, Imad M. Tleyjeh
26 [GO] 2021―Jun―30 Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis Eva Schrezenmeier, Leon Bergfeld, David Hillus, Joerg-Detlev Lippert, Ulrike Weber, Pinkus Tober-Lau, et al. (+13)
27 [GO] 2021―Jun―30 Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection Narjes Saheb Sharif-Askari, Fatemeh Saheb Sharif-Askari, Samrein B. M. Ahmed, Suad Hannawi, Rifat Hamoudi, Qutayba Hamid, Rabih Halwani
28 [GO] 2021―Jun―30 Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update Uttpal Anand, Shweta Jakhmola, Omkar Indari, Hem Chandra Jha, Zhe-Sheng Chen, Vijay Tripathi, José M. Pérez de la Lastra
29 [GO] 2021―Jun―29 Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design Daniel Ellis, Natalie Brunette, Katharine H. D. Crawford, Alexandra C. Walls, Minh N. Pham, Chengbo Chen, et al. (+21)
30 [GO] 2021―Jun―28 Case Report: Systemic Sclerosis After Covid-19 Infection Serena Fineschi
31 [GO] 2021―Jun―28 Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients Sarah Musa Hammoudeh, Arabella Musa Hammoudeh, Poorna Manasa Bhamidimarri, Habiba Al Safar, Bassam Mahboub, Axel Künstner, et al. (+5)
32 [GO] 2021―Jun―28 Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir Yi-Hao Chan, Barnaby E. Young, Siew-Wai Fong, Ying Ding, Yun Shan Goh, Rhonda Sin-Ling Chee, et al. (+7)
33 [GO] 2021―Jun―28 Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning Bruce K. Patterson, Jose Guevara-Coto, Ram Yogendra, Edgar B. Francisco, Emily Long, Amruta Pise, et al. (+4)
34 [GO] 2021―Jun―28 Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications Giuseppe Derosa, Pamela Maffioli, Angela D’Angelo, Francesco Di Pierro
35 [GO] 2021―Jun―28 Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection Mingxi Li, Jingao Guo, Shuaiyao Lu, Runhong Zhou, Hongyang Shi, Xuanling Shi, et al. (+25)
36 [GO] 2021―Jun―25 Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism Ying Shao, Jason Saredy, Keman Xu, Yu Sun, Fatma Saaoud, Charles Drummer, et al. (+7)
37 [GO] 2021―Jun―25 RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses Takahisa Kouwaki, Tasuku Nishimura, Guanming Wang, Hiroyuki Oshiumi
38 [GO] 2021―Jun―25 Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets Shane Riddell, Sarah Goldie, Alexander J. McAuley, Michael J. Kuiper, Peter A. Durr, Kim R. Blasdell, et al. (+5)
39 [GO] 2021―Jun―24 A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm Mohd Rehan, Firoz Ahmed, Saad M. Howladar, Mohammed Y. Refai, Hanadi M. Baeissa, Torki A. Zughaibi, et al. (+2)
40 [GO] 2021―Jun―23 Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19 Akash Gupta, Hyung J. Chun
41 [GO] 2021―Jun―23 EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients Thomas Luft, Clemens-Martin Wendtner, Florentina Kosely, Aleksandar Radujkovic, Axel Benner, Felix Korell, et al. (+4)
42 [GO] 2021―Jun―23 Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk Claudia Strafella, Valerio Caputo, Gisella Guerrera, Andrea Termine, Carlo Fabrizio, Raffaella Cascella, et al. (+8)
43 [GO] 2021―Jun―23 SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages Ioanna Pantazi, Ahmed A. Al-Qahtani, Fatimah S Alhamlan, Hani Alothaid, Sabine Matou-Nasri, George Sourvinos, et al. (+2)
44 [GO] 2021―Jun―23 Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype Amelia C. Trombetta, Guilherme B. Farias, André M. C. Gomes, Ana Godinho-Santos, Pedro Rosmaninho, Carolina M. Conceição, et al. (+9)
45 [GO] 2021―Jun―21 Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action? Hashim Islam, Thomas C. Chamberlain, Alice L. Mui, Jonathan P. Little
46 [GO] 2021―Jun―21 Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey Leslie Y. T. Leung, Srijit Khan, Patrick Budylowski, Zhijie Li, Sofiya Goroshko, Yanling Liu, et al. (+5)
47 [GO] 2021―Jun―21 Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Christina Woopen, Katharina Schleußner, Katja Akgün, Tjalf Ziemssen
48 [GO] 2021―Jun―18 Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19 Marianna Rowlands, Florencia Segal, Dominik Hartl
49 [GO] 2021―Jun―18 COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality Radheshyam Maurya, Prince Sebastian, Madhulika Namdeo, Moodu Devender, Arieh Gertler
50 [GO] 2021―Jun―17 Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2 Diego Fernández-Lázaro, Cesar I. Fernandez-Lazaro, Juan Mielgo-Ayuso, David P. Adams, Juan Luis García Hernández, Jerónimo González-Bernal, Marcela González-Gross
51 [GO] 2021―Jun―17 Chronic Immune Activation and CD4+ T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy Dawit Wolday, Francis M. Ndungu, Gloria P. Gómez-Pérez, Tobias F. Rinke de Wit
52 [GO] 2021―Jun―17 The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom Jiajing Wu, Li Zhang, Yue Zhang, Haixin Wang, Ruxia Ding, Jianhui Nie, et al. (+8)
53 [GO] 2021―Jun―16 Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset Tiandan Xiang, Boyun Liang, Yaohui Fang, Sihong Lu, Sumeng Li, Hua Wang, et al. (+13)
54 [GO] 2021―Jun―16 A Comparative Analysis of Coronavirus Nucleocapsid (N) Proteins Reveals the SADS-CoV N Protein Antagonizes IFN-β Production by Inducing Ubiquitination of RIG-I Yan Liu, Qi-Zhang Liang, Wan Lu, Yong-Le Yang, Ruiai Chen, Yao-Wei Huang, Bin Wang
55 [GO] 2021―Jun―16 The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients Emanuel Zitt, Tamara Davidovic, Judith Schimpf, Armin Abbassi-Nik, Beatrix Mutschlechner, Hanno Ulmer, et al. (+4)
56 [GO] 2021―Jun―15 Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses Georgia Bullen, Jacob D. Galson, Gareth Hall, Pedro Villar, Lien Moreels, Line Ledsgaard, et al. (+29)
57 [GO] 2021―Jun―14 Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients Eliott Lafon, Gabriel Diem, Christina Witting, Viktoria Zaderer, Rosa Maria Bellmann-Weiler, Markus Reindl, et al. (+10)
58 [GO] 2021―Jun―14 Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients Ikram Omar Osman, Cléa Melenotte, Philippe Brouqui, Matthieu Million, Jean-Christophe Lagier, Philippe Parola, et al. (+6)
59 [GO] 2021―Jun―14 Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States Shu-Fang Shih, Abram L. Wagner, Nina B. Masters, Lisa A. Prosser, Yihan Lu, Brian J. Zikmund-Fisher
60 [GO] 2021―Jun―14 sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection Dhanashree Jagtap, Vikrant M. Bhor, Shilpa Bhowmick, Nandini Kasarpalkar, Pooja Sagvekar, Bhalchandra Kulkarni, et al. (+14)
61 [GO] 2021―Jun―11 Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies Satoshi Gando, Takeshi Wada
62 [GO] 2021―Jun―11 Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics Krzysztof Laudanski, Hajj Jihane, Brook Antalosky, Danyal Ghani, Uyen Phan, Ruth Hernandez, et al. (+4)
63 [GO] 2021―Jun―11 How Children Are Protected From COVID-19? A Historical, Clinical, and Pathophysiological Approach to Address COVID-19 Susceptibility Magdalena Anna Massalska, Hans-Jürgen Gober
64 [GO] 2021―Jun―11 SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology Augusta Ortolan, Mariagrazia Lorenzin, Chiara Cosma, Giacomo Cozzi, Andrea Padoan, Andrea Doria, et al. (+2)
65 [GO] 2021―Jun―11 Targeting Future Pandemics, a Case for De Novo Purine Synthesis and Basic Research Randall C. Mazzarino
66 [GO] 2021―Jun―10 Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI Fabian Bohländer, Dennis Riehl, Sabrina Weißmüller, Marcus Gutscher, Jörg Schüttrumpf, Stefanie Faust
67 [GO] 2021―Jun―10 Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease Siggeir F. Brynjolfsson, Hildur Sigurgrimsdottir, Elin D. Einarsdottir, Gudrun A. Bjornsdottir, Brynja Armannsdottir, Gudrun E. Baldvinsdottir, et al. (+7)
68 [GO] 2021―Jun―09 SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells Hua Geng, Saravanan Subramanian, Longtao Wu, Heng-Fu Bu, Xiao Wang, Chao Du, et al. (+2)
69 [GO] 2021―Jun―09 Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients Liwen Wei, Yuqi Shang, Xi Liu, Xinghua Li, Gongqi Chen, Siping Liang, et al. (+5)
70 [GO] 2021―Jun―09 Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients Leila B. Giron, Harsh Dweep, Xiangfan Yin, Han Wang, Mohammad Damra, Aaron R. Goldman, et al. (+12)
71 [GO] 2021―Jun―09 Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection Irene Ramos, Carl Goforth, Alessandra Soares-Schanoski, Dawn L. Weir, Emily C. Samuels, Shreshta Phogat, et al. (+22)
72 [GO] 2021―Jun―07 Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis? Sandra M. Gonzalez, Abu Bakar Siddik, Ruey-Chyi Su
73 [GO] 2021―Jun―07 PD-L1 Dysregulation in COVID-19 Patients Francesco Sabbatino, Valeria Conti, Gianluigi Franci, Carmine Sellitto, Valentina Manzo, Pasquale Pagliano, et al. (+14)
74 [GO] 2021―Jun―07 Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression Angelo Zinellu, Arduino A. Mangoni
75 [GO] 2021―Jun―04 SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage Yongjun Sui, Jianping Li, David J. Venzon, Jay A. Berzofsky
76 [GO] 2021―Jun―04 Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern Ashlesha Deshpande, Bethany D. Harris, Luis Martinez-Sobrido, James J. Kobie, Mark R. Walter
77 [GO] 2021―Jun―03 Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients Zhenyan Wang, Jun Chen, Cuiyun Zhu, Li Liu, Tangkai Qi, Yinzhong Shen, et al. (+6)
78 [GO] 2021―Jun―03 Inefficient Placental Virus Replication and Absence of Neonatal Cell-Specific Immunity Upon Sars-CoV-2 Infection During Pregnancy Ann-Christin Tallarek, Christopher Urbschat, Luis Fonseca Brito, Stephanie Stanelle-Bertram, Susanne Krasemann, Giada Frascaroli, et al. (+11)
79 [GO] 2021―Jun―02 Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients Marcela Valverde-Monge, José A. Cañas, Blanca Barroso, Diana Betancor, Laura Ortega-Martin, Alicia Gómez-López, et al. (+4)
80 [GO] 2021―Jun―02 Immunothrombosis in Acute Respiratory Dysfunction of COVID-19 Xiang-Zhi Fang, Ya-Xin Wang, Ji-Qain Xu, Ya-Jun He, Zhe-Kang Peng, You Shang
81 [GO] 2021―Jun―02 Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients Andrzej Lange, Janusz Lange, Emilia Jaskuła
82 [GO] 2021―Jun―02 Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets Jon Hazeldine, Janet M. Lord
83 [GO] 2021―Jun―02 Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With In Vitro Derived Conventional Dendritic Cells Yanli Li, Enric Mateu
84 [GO] 2021―Jun―01 Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19. A Case Report Juan Carlos Ruiz-Rodríguez, Luis Chiscano-Camón, Clara Palmada, Adolf Ruiz-Sanmartin, Marina García-de-Acilu, Erika Plata-Menchaca, et al. (+5)
85 [GO] 2021―May―28 Potent and Persistent Antibody Response in COVID-19 Recovered Patients Xiaodong Tian, Ling Liu, Wenguo Jiang, He Zhang, Wenjun Liu, Jing Li
86 [GO] 2021―May―28 Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses Yingying Cao, Xintian Xu, Simo Kitanovski, Lina Song, Jun Wang, Pei Hao, Daniel Hoffmann
87 [GO] 2021―May―28 Prospects of Neutralizing Nanobodies Against SARS-CoV-2 Fangfang Chen, Zhihong Liu, Fan Jiang
88 [GO] 2021―May―28 Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity Alexander A. Lehmann, Greg A. Kirchenbaum, Ting Zhang, Pedro A. Reche, Paul V. Lehmann
89 [GO] 2021―May―26 Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity Lorena Vigón, Daniel Fuertes, Javier García-Pérez, Montserrat Torres, Sara Rodríguez-Mora, Elena Mateos, et al. (+11)
90 [GO] 2021―May―26 Association Between COVID-19 Pregnant Women Symptoms Severity and Placental Morphologic Features Patricia Zadorosnei Rebutini, Aline Cristina Zanchettin, Emanuele Therezinha Schueda Stonoga, Daniele Margarita Marani Prá, André Luiz Parmegiani de Oliveira, Felipe da Silva Dezidério, et al. (+14)
91 [GO] 2021―May―26 Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection Marc A. Niles, Patricia Gogesch, Stefanie Kronhart, Samira Ortega Iannazzo, Georg Kochs, Zoe Waibler, Martina Anzaghe
92 [GO] 2021―May―25 A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19 Joo Guan Yeo, Jing Yao Leong, Shi Huan Tay, Karen Donceras Nadua, Danielle E. Anderson, Amanda Jin Mei Lim, et al. (+27)
93 [GO] 2021―May―24 Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19 Vanessa Chilunda, Pablo Martinez-Aguado, Li C. Xia, Laura Cheney, Aniella Murphy, Veronica Veksler, et al. (+3)
94 [GO] 2021―May―24 Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model Tripti Shrivastava, Balwant Singh, Zaigham Abbas Rizvi, Rohit Verma, Sandeep Goswami, Preeti Vishwakarma, et al. (+6)
95 [GO] 2021―May―21 COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says Gang Chen, Xiaolin Li, Meixing Sun, Yangzhong Zhou, Meifang Yin, Bin Zhao, Xuemei Li
96 [GO] 2021―May―20 Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay Isabel Brand, Leonard Gilberg, Jan Bruger, Mercè Garí, Andreas Wieser, Tabea M. Eser, et al. (+16)
97 [GO] 2021―May―19 Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19? Giovanni A. Rossi, Oliviero Sacco, Antonino Capizzi, Paola Mastromarino
98 [GO] 2021―May―18 SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1 Liyan Sui, Yinghua Zhao, Wenfang Wang, Ping Wu, Zedong Wang, Yang Yu, et al. (+3)
99 [GO] 2021―May―18 Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003 Wen-Pin Tseng, Jhong-Lin Wu, Chen-Chi Wu, Kuan-Ting Kuo, Chien-Hao Lin, Ming-Yi Chung, et al. (+7)
100 [GO] 2021―May―14 Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients Esther J. Nossent, Alex R. Schuurman, Tom D.Y. Reijnders, Anno Saris, Ilse Jongerius, Siebe G. Blok, et al. (+8)
101 [GO] 2021―May―14 Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles Miao-Hsi Hsieh, Nazar Beirag, Valarmathy Murugaiah, Yu-Chi Chou, Wen-Shuo Kuo, Hui-Fang Kao, et al. (+3)
102 [GO] 2021―May―13 Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19 Hassan A. Alhazmi, Asim Najmi, Sadique A. Javed, Shahnaz Sultana, Mohammed Al Bratty, Hafiz A. Makeen, et al. (+5)
103 [GO] 2021―May―13 The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19? Xiaofang Wang, Panpan Yi, Yuejin Liang
104 [GO] 2021―May―13 Identify. Quantify. Predict. Why Immunologists Should Widely Use Molecular Imaging for Coronavirus Disease 2019 Freimut D. Juengling, Antonio Maldonado, Frank Wuest, Thomas H. Schindler
105 [GO] 2021―May―13 Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome Jose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, Montserrat Sandoval-Vega, Citlaltepetl Salinas-Lara, Carlos Sánchez-Garibay, et al. (+23)
106 [GO] 2021―May―12 Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis Rafaela Pires da Silva, João Ismael Budelon Gonçalves, Rafael Fernandes Zanin, Felipe Barreto Schuch, Ana Paula Duarte de Souza
107 [GO] 2021―May―11 Case Report: Successful Response to Intravenous Immunoglobulin and Steroid Pulses in a Renal Transplant Recipient With Severe Covid-19 Disease and Associated Acute Allograft Failure Pedro Rosa-Guerrero, Antonio Trujillo-Aguilera, Juan Molina, Ana Navas, Cristina López-Martín, Aurora Jurado, et al. (+2)
108 [GO] 2021―May―11 Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2 Pankaj Ahluwalia, Kumar Vaibhav, Meenakshi Ahluwalia, Ashis K. Mondal, Nikhil Sahajpal, Amyn M. Rojiani, Ravindra Kolhe
109 [GO] 2021―May―10 SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms Shahrzad Shoraka, Maria Lucia Brito Ferreira, Seyed Reza Mohebbi, Amir Ghaemi
110 [GO] 2021―May―10 Vitamin C May Increase the Recovery Rate of Outpatient Cases of SARS-CoV-2 Infection by 70%: Reanalysis of the COVID A to Z Randomized Clinical Trial Harri Hemilä, Anitra Carr, Elizabeth Chalker
111 [GO] 2021―May―10 The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome Anna Kosyreva, Dzhuliia Dzhalilova, Anastasia Lokhonina, Polina Vishnyakova, Timur Fatkhudinov
112 [GO] 2021―May―07 Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health Liam Townsend, Adam H. Dyer, Aifric Naughton, Rachel Kiersey, Dean Holden, Mary Gardiner, et al. (+12)
113 [GO] 2021―May―07 Associations of D-Dimer on Admission and Clinical Features of COVID-19 Patients: A Systematic Review, Meta-Analysis, and Meta-Regression Runzhen Zhao, Zhenlei Su, Andrey A. Komissarov, Shan-Lu Liu, Guohua Yi, Steven Idell, et al. (+2)
114 [GO] 2021―May―07 Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality Zena Wehbe, Safaa Hisham Hammoud, Hadi M. Yassine, Manal Fardoun, Ahmed F. El-Yazbi, Ali H. Eid
115 [GO] 2021―May―06 Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling Esra’a Keewan, Shazia Beg, Saleh A. Naser
116 [GO] 2021―May―05 Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis Ayat Zawawi, Abdallah Y. Naser, Hassan Alwafi, Faisal Minsahwi
117 [GO] 2021―May―03 Immune Response to COVID-19 During Pregnancy Ge Chen, Qiuyue Liao, Jihui Ai, Bin Yang, Hualin Bai, Jing Chen, et al. (+4)
118 [GO] 2021―May―03 Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients Esperanza Martín-Sánchez, Juan José Garcés, Catarina Maia, Susana Inogés, Ascensión López-Díaz de Cerio, Francisco Carmona-Torre, et al. (+21)
119 [GO] 2021―May―03 False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases Nastya Kharlamova, Nicky Dunn, Sahl K. Bedri, Svante Jerling, Malin Almgren, Francesca Faustini, et al. (+11)
120 [GO] 2021―May―03 CD4+ T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein Pavla Taborska, Zuzana Strizova, Dmitry Stakheev, Ludek Sojka, Jirina Bartunkova, Daniel Smrz
121 [GO] 2021―May―03 Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure Verena Keitel, Johannes Georg Bode, Torsten Feldt, Andreas Walker, Lisa Müller, Anselm Kunstein, et al. (+21)
122 [GO] 2021―Apr―30 Cellular Immune Response to COVID-19 and Potential Immune Modulators Xi Zhou, Qing Ye
123 [GO] 2021―Apr―29 Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease Nicholas R. Medjeral-Thomas, Anne Troldborg, Annette G. Hansen, Jack Gisby, Candice L. Clarke, Maria Prendecki, et al. (+9)
124 [GO] 2021―Apr―29 Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation Emanuel Della-Torre, Marco Lanzillotta, Corrado Campochiaro, Giulio Cavalli, Giacomo De Luca, Alessandro Tomelleri, et al. (+10)
125 [GO] 2021―Apr―29 Commentary: Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment Juliana Lott Carvalho, Amandda Evelin Silva-Carvalho, Emãnuella Melgaço Garcez, Felipe Saldanha-Araujo
126 [GO] 2021―Apr―29 NSP2 Is Important for Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus to Trigger High Fever-Related COX-2-PGE2 Pathway in Pigs Li Du, Honglei Wang, Fang Liu, Zeyu Wei, Changjiang Weng, Jun Tang, Wen-hai Feng
127 [GO] 2021―Apr―28 Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration Ruirong Chen, Zhien Lan, Jujian Ye, Limin Pang, Yi Liu, Wei Wu, et al. (+3)
128 [GO] 2021―Apr―28 High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients Uri Greenbaum, Kimberly Klein, Fernando Martinez, Juhee Song, Peter F. Thall, Jeremy L. Ramdial, et al. (+15)
129 [GO] 2021―Apr―28 SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses Katja G. Schmidt, Krystelle Nganou-Makamdop, Matthias Tenbusch, Boutaina El Kenz, Clara Maier, Dennis Lapuente, et al. (+5)
130 [GO] 2021―Apr―28 SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs Qun Xiang, Zeqing Feng, Bo Diao, Chao Tu, Qinghua Qiao, Han Yang, et al. (+10)
131 [GO] 2021―Apr―28 A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain Ling Niu, Kathryn N. Wittrock, Gage C. Clabaugh, Vikram Srivastava, Michael W. Cho
132 [GO] 2021―Apr―26 Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One! Francesca Coperchini, Luca Chiovato, Mario Rotondi
133 [GO] 2021―Apr―26 Neurological Symptoms of COVID-19: The Zonulin Hypothesis Sílvia Llorens, Eduardo Nava, Mónica Muñoz-López, Álvaro Sánchez-Larsen, Tomás Segura
134 [GO] 2021―Apr―26 Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222) Gustavo C. Román, Fernando Gracia, Antonio Torres, Alexis Palacios, Karla Gracia, Diógenes Harris
135 [GO] 2021―Apr―22 Investigation of Extracellular Vesicles From SARS-CoV-2 Infected Specimens: A Safety Perspective Yury O. Nunez Lopez, Anna Casu, Richard E. Pratley
136 [GO] 2021―Apr―22 Enhancing the Prefusion Conformational Stability of SARS-CoV-2 Spike Protein Through Structure-Guided Design Timothy P. Riley, Hui-Ting Chou, Ruozhen Hu, Krzysztof P. Bzymek, Ana R. Correia, Alexander C. Partin, et al. (+6)
137 [GO] 2021―Apr―21 Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1) José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Alfredo Cruz-Lagunas, Tatiana Sofía Rodríguez-Reyna, Gustavo Ramírez-Martínez, Montserrat Sandoval-Vega, et al. (+34)
138 [GO] 2021―Apr―20 Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19 Tanja M. Müller, Emily Becker, Maximilian Wiendl, Lisa Lou Schulze, Caroline Voskens, Simon Völkl, et al. (+3)
139 [GO] 2021―Apr―19 Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China Wei Cao, Xiaosheng Liu, Ke Hong, Zhiyong Ma, Yuelun Zhang, Ling Lin, et al. (+5)
140 [GO] 2021―Apr―16 Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus Yufeng Shang, Tao Liu, Jingfeng Li, Natasha Mupeta Kaweme, Xinghuan Wang, Fuling Zhou
141 [GO] 2021―Apr―16 Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab Jo Linda Sinagra, Claudio Vedovelli, Raffaella Binazzi, Adele Salemme, Francesco Moro, Cinzia Mazzanti, et al. (+2)
142 [GO] 2021―Apr―15 How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group Francesca Ferretti, Rosanna Cannatelli, Maurizio Benucci, Stefania Carmagnola, Emilio Clementi, Piergiorgio Danelli, et al. (+21)
143 [GO] 2021―Apr―15 Antibody Responses in COVID-19: A Review Mateo Chvatal-Medina, Yorjagis Mendez-Cortina, Pablo J. Patiño, Paula A. Velilla, Maria T. Rugeles
144 [GO] 2021―Apr―15 SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights Qiao Zhou, Jayakumar Vadakekolathu, Abdulla Watad, Kassem Sharif, Tobias Russell, Hannah Rowe, et al. (+13)
145 [GO] 2021―Apr―14 Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019 Furong Qi, Wenbo Zhang, Jialu Huang, Lili Fu, Jinfang Zhao
146 [GO] 2021―Apr―14 Corrigendum: Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective Indu Khatri, Frank J. T. Staal, Jacques J. M. van Dongen
147 [GO] 2021―Apr―14 SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia Ritu Mishra, Akhil C. Banerjea
148 [GO] 2021―Apr―13 Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
149 [GO] 2021―Apr―12 Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19 Jintao Zhang, Chunyuan Zhao, Wei Zhao
150 [GO] 2021―Apr―12 COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations Qian He, Qunying Mao, Jialu Zhang, Lianlian Bian, Fan Gao, Junzhi Wang, et al. (+2)
151 [GO] 2021―Apr―12 Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2 Kathrin Becker, Georg Beythien, Nicole de Buhr, Stephanie Stanelle-Bertram, Berfin Tuku, Nancy Mounogou Kouassi, et al. (+6)
152 [GO] 2021―Apr―09 Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection Rachel R. Yuen, Dylan Steiner, Riley M.F. Pihl, Elizabeth Chavez, Alex Olson, Erika L. Smith, et al. (+17)
153 [GO] 2021―Apr―07 Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19 Nicholas Stoy
154 [GO] 2021―Apr―07 Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome Steffen Dickel, Clemens Grimm, Katharina Amschler, Sebastian Uwe Schnitzler, Julie Schanz, Onnen Moerer, et al. (+3)
155 [GO] 2021―Apr―07 Breastfeeding and COVID-19: From Nutrition to Immunity Emilia Vassilopoulou, Gavriela Feketea, Lemonica Koumbi, Christina Mesiari, Elena Camelia Berghea, George N. Konstantinou
156 [GO] 2021―Apr―01 Commentary: The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19 Harri Hemilä, Elizabeth Chalker
157 [GO] 2021―Apr―01 Genetics Insight for COVID-19 Susceptibility and Severity: A Review Ingrid Fricke-Galindo, Ramcés Falfán-Valencia
158 [GO] 2021―Mar―31 Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19 Marina Luise Viola Azevedo, Aline Cristina Zanchettin, Caroline Busatta Vaz de Paula, Jarbas da Silva Motta Júnior, Mineia Alessandra Scaranello Malaquias, Sonia Mara Raboni, et al. (+10)
159 [GO] 2021―Mar―31 Why Haven’t We Found an Effective Treatment for COVID-19? Alexander James Spicer, Sirpa Jalkanen
160 [GO] 2021―Mar―30 Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity Patricia Lamadrid, Marta Alonso-Peña, David San Segundo, Mayte Arias-Loste, Javier Crespo, Marcos Lopez-Hoyos
161 [GO] 2021―Mar―30 Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities Zena Wehbe, Maya Wehbe, Rabah Iratni, Gianfranco Pintus, Hassan Zaraket, Hadi M. Yassine, Ali H. Eid
162 [GO] 2021―Mar―29 Commentary: Beyond “TRIM” Benefits of β-Glucan by Blood Glucose and Lipid Balancing Potentials in Its Defense Against COVID-19 Nobunao Ikewaki, Vidyasagar Devaprasad Dedeepiya, Masaru Iwasaki, Samuel J. K. Abraham
163 [GO] 2021―Mar―29 Age-Related Dynamics of Lung-Resident Memory CD8+ T Cells in the Age of COVID-19 Nick P. Goplen, In Su Cheon, Jie Sun
164 [GO] 2021―Mar―29 Integrin Activation Enables Sensitive Detection of Functional CD4+ and CD8+ T Cells: Application to Characterize SARS-CoV-2 Immunity Anna Schöllhorn, Juliane Schuhmacher, Luciana Besedovsky, Rolf Fendel, Anja T. R. Jensen, Stefan Stevanović, et al. (+5)
165 [GO] 2021―Mar―29 How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era Jonathan Caron, Laura Alice Ridgley, Mark Bodman-Smith
166 [GO] 2021―Mar―26 Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro Preeti Vishwakarma, Naveen Yadav, Zaigham Abbas Rizvi, Naseem Ahmed Khan, Adarsh Kumar Chiranjivi, Shailendra Mani, et al. (+7)
167 [GO] 2021―Mar―26 Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2 Diana Garcia-del-Barco, Daniela Risco-Acevedo, Jorge Berlanga-Acosta, Frank Daniel Martos-Benítez, Gerardo Guillén-Nieto
168 [GO] 2021―Mar―25 Neutrophils in COVID-19 Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, Jonas Schulte-Schrepping, Kevin Baßler, Joachim L. Schultze, Anna C. Aschenbrenner
169 [GO] 2021―Mar―25 Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection György Sinkovits, Blanka Mező, Marienn Réti, Veronika Müller, Zsolt Iványi, János Gál, et al. (+16)
170 [GO] 2021―Mar―25 Transcriptional and Immunologic Correlates of Response to Pandemic Influenza Vaccine in Aviremic, HIV-Infected Children Lesley R. de Armas, Varghese George, Abdelali Filali-Mouhim, Courtney Steel, Anita Parmigiani, Coleen K. Cunningham, et al. (+5)
171 [GO] 2021―Mar―24 COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire Nabila Seddiki, Martyn French
172 [GO] 2021―Mar―24 Understanding of COVID-19 Pathology: Much More Attention to Plasma Proteins Masahiro Nishibori, Barbara S. Stonestreet
173 [GO] 2021―Mar―23 Bovine Coronavirus Immune Milk Against COVID-19 Antonio Arenas, Carmen Borge, Alfonso Carbonero, Ignacio Garcia-Bocanegra, David Cano-Terriza, Javier Caballero, Antonio Arenas-Montes
174 [GO] 2021―Mar―23 SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients Tatjana Schwarz, Kirsten Heiss, Yuvaraj Mahendran, Fiordiligie Casilag, Florian Kurth, Leif E. Sander, et al. (+7)
175 [GO] 2021―Mar―23 COVID-19-A Theory of Autoimmunity Against ACE-2 Explained Philip McMillan, Thomas Dexhiemer, Richard R. Neubig, Bruce D. Uhal
176 [GO] 2021―Mar―22 A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2 Xiaojian Han, Yingming Wang, Shenglong Li, Chao Hu, Tingting Li, Chenjian Gu, et al. (+31)
177 [GO] 2021―Mar―19 Immunity to SARS-CoV-2: Lessons Learned Jaime Fergie, Amit Srivastava
178 [GO] 2021―Mar―18 Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic Olufunto A. Olusanya, Robert A. Bednarczyk, Robert L. Davis, Arash Shaban-Nejad
179 [GO] 2021―Mar―18 Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients Massimo Caracciolo, Pierpaolo Correale, Carmelo Mangano, Giuseppe Foti, Carmela Falcone, Sebastiano Macheda, et al. (+14)
180 [GO] 2021―Mar―17 The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study Ana Copaescu, Fiona James, Effie Mouhtouris, Sara Vogrin, Olivia C. Smibert, Claire L. Gordon, et al. (+3)
181 [GO] 2021―Mar―16 Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues Karthikeyan Subbarayan, Kamatchi Ulagappan, Claudia Wickenhauser, Michael Bachmann, Barbara Seliger
182 [GO] 2021―Mar―15 Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China Xia Feng, Jiming Yin, Jiaying Zhang, Yaling Hu, Yabo Ouyang, Shubin Qiao, et al. (+8)
183 [GO] 2021―Mar―12 Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development Marc Baay, Pieter Neels
184 [GO] 2021―Mar―12 Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review Kuo-Tung Tang, Bo-Chueh Hsu, Der-Yuan Chen
185 [GO] 2021―Mar―12 Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results Andrea Lombardi, Giorgio Bozzi, Riccardo Ungaro, Simone Villa, Valeria Castelli, Davide Mangioni, et al. (+3)
186 [GO] 2021―Mar―11 T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19 Olatz Zenarruzabeitia, Gabirel Astarloa-Pando, Iñigo Terrén, Ane Orrantia, Raquel Pérez-Garay, Iratxe Seijas-Betolaza, et al. (+5)
187 [GO] 2021―Mar―11 Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection Asgar Ansari, Rakesh Arya, Shilpa Sachan, Someshwar Nath Jha, Anurag Kalia, Anupam Lall, et al. (+6)
188 [GO] 2021―Mar―11 Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment Miguel Angel Martinez
189 [GO] 2021―Mar―11 Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Ge Li, Aiping Wang, Yumei Chen, Yaning Sun, Yongkun Du, Xun Wang, et al. (+4)
190 [GO] 2021―Mar―11 Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen Vikram Srivastava, Ling Niu, Kruttika S. Phadke, Bryan H. Bellaire, Michael W. Cho
191 [GO] 2021―Mar―10 Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody Simon Gebremeskel, Julia Schanin, Krysta M. Coyle, Melina Butuci, Thuy Luu, Emily C. Brock, et al. (+8)
192 [GO] 2021―Mar―09 The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic Priyanka Shah, Gabriela A. Canziani, Erik P. Carter, Irwin Chaiken
193 [GO] 2021―Mar―09 Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients Marco Contoli, Alberto Papi, Luca Tomassetti, Paola Rizzo, Francesco Vieceli Dalla Sega, Francesca Fortini, et al. (+11)
194 [GO] 2021―Mar―09 The Local and Systemic Humoral Immune Response Against Homologous and Heterologous Strains of the Type 2 Porcine Reproductive and Respiratory Syndrome Virus Andrew R. Kick, Amanda F. Amaral, Alba Frias-De-Diego, Lizette M. Cortes, Jonathan E. Fogle, Elisa Crisci, et al. (+2)
195 [GO] 2021―Mar―08 Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C) Gavriela Feketea, Vasiliki Vlacha, Ioana Corina Bocsan, Emilia Vassilopoulou, Luminita Aurelia Stanciu, Mihnea Zdrenghea
196 [GO] 2021―Mar―08 The BCG Vaccine for COVID-19: First Verdict and Future Directions Maria Gonzalez-Perez, Rodrigo Sanchez-Tarjuelo, Boris Shor, Estanislao Nistal-Villan, Jordi Ochando
197 [GO] 2021―Mar―08 Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification Vince Kornél Grolmusz, Anikó Bozsik, János Papp, Attila Patócs
198 [GO] 2021―Mar―04 The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients Huanle Luo, Tingting Jia, Jiamin Chen, Shike Zeng, Zengzhao Qiu, Shu Wu, et al. (+14)
199 [GO] 2021―Mar―04 Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment Jian Wu, Jiawei Shen, Ying Han, Qinghua Qiao, Wei Dai, Bangshun He, et al. (+12)
200 [GO] 2021―Mar―03 Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19 Holger A. Lindner, Sonia Y. Velásquez, Manfred Thiel, Thomas Kirschning
201 [GO] 2021―Mar―01 SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients Marton Olbei, Isabelle Hautefort, Dezso Modos, Agatha Treveil, Martina Poletti, Lejla Gul, et al. (+2)
202 [GO] 2021―Feb―26 A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation Hyein Jeong, Yu-Min Choi, Hyejun Seo, Bum-Joon Kim
203 [GO] 2021―Feb―26 A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic Chris R. Triggle, Devendra Bansal, Hong Ding, Md Mazharul Islam, Elmoubashar Abu Baker Abd Farag, Hamad Abdel Hadi, Ali A. Sultan
204 [GO] 2021―Feb―26 COVID-19 Impairs Immune Response to Candida albicans Dominique Moser, Katharina Biere, Bing Han, Marion Hoerl, Gustav Schelling, Alexander Choukér, Tobias Woehrle
205 [GO] 2021―Feb―26 Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia Maria Antonella Zingaropoli, Parni Nijhawan, Anna Carraro, Patrizia Pasculli, Paola Zuccalà, Valentina Perri, et al. (+10)
206 [GO] 2021―Feb―26 Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children Men-Ren Chen, Ho-Chang Kuo, Yann-Jinn Lee, Hsin Chi, Sung Chou Li, Hung-Chang Lee, Kuender D. Yang
207 [GO] 2021―Feb―26 CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome Jose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, Montserrat Sandoval-Vega, Citlaltepetl Salinas-Lara, Carlos Sánchez-Garibay, et al. (+23)
208 [GO] 2021―Feb―25 In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection Juliana de Melo Batista dos Santos, Camila Pereira Soares, Fernanda Rodrigues Monteiro, Ralyria Mello, Jonatas Bussador do Amaral, Andressa Simões Aguiar, et al. (+14)
209 [GO] 2021―Feb―24 Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies Darrell O. Ricke
210 [GO] 2021―Feb―24 Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19 Maria G. Balta, Evangelos Papathanasiou, Panagiotis F. Christopoulos
211 [GO] 2021―Feb―24 Microbiota Modulation of the Gut-Lung Axis in COVID-19 Gislane Lelis Vilela de Oliveira, Camilla Narjara Simão Oliveira, Camila Figueiredo Pinzan, Larissa Vedovato Vilela de Salis, Cristina Ribeiro de Barros Cardoso
212 [GO] 2021―Feb―24 Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients Shun Li, Bin Wu, Yun Ling, Mingquan Guo, Boyin Qin, Xiaonan Ren, et al. (+19)
213 [GO] 2021―Feb―23 Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19 Maxim Shkurnikov, Stepan Nersisyan, Tatjana Jankevic, Alexei Galatenko, Ivan Gordeev, Valery Vechorko, Alexander Tonevitsky
214 [GO] 2021―Feb―22 Glycocalyx as Possible Limiting Factor in COVID-19 Patricia P. Wadowski, Bernd Jilma, Christoph W. Kopp, Sebastian Ertl, Thomas Gremmel, Renate Koppensteiner
215 [GO] 2021―Feb―22 Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients Sergej Tomić, Jelena Đokić, Dejan Stevanović, Nataša Ilić, Alisa Gruden-Movsesijan, Miroslav Dinić, et al. (+7)
216 [GO] 2021―Feb―22 The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System Miklós Lipcsey, Barbro Persson, Oskar Eriksson, Anna M. Blom, Karin Fromell, Michael Hultström, et al. (+4)
217 [GO] 2021―Feb―22 Swine Acute Diarrhea Syndrome Coronavirus Nucleocapsid Protein Antagonizes Interferon-β Production via Blocking the Interaction Between TRAF3 and TBK1 Zhihai Zhou, Yuan Sun, Jingya Xu, Xiaoyu Tang, Ling Zhou, Qianniu Li, et al. (+2)
218 [GO] 2021―Feb―22 Isolation of Porcine Reproductive and Respiratory Syndrome Virus GP5-Specific, Neutralizing Monoclonal Antibodies From Hyperimmune Sows Jordan E. Young, Cheryl M. T. Dvorak, Simon P. Graham, Michael P. Murtaugh
219 [GO] 2021―Feb―20 Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19 Qiong Zhang, Yuting Meng, Kaihang Wang, Xujun Zhang, Wenbiao Chen, Jifang Sheng, et al. (+3)
220 [GO] 2021―Feb―20 Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Plasmodium falciparum Infection Be Protective? Allan Kalungi, Eugene Kinyanda, Dickens Howard Akena, Pontiano Kaleebu, Innocent M. Bisangwa
221 [GO] 2021―Feb―20 Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia André Santa Cruz, Ana Mendes-Frias, Ana Isabel Oliveira, Luís Dias, Ana Rita Matos, Alexandre Carvalho, et al. (+4)
222 [GO] 2021―Feb―20 High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China Wei Cao, Xiaosheng Liu, Ke Hong, Zhiyong Ma, Yuelun Zhang, Ling Lin, et al. (+5)
223 [GO] 2021―Feb―18 Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study Jing Zhang, Zhihua Wang, Xiong Wang, Zhiquan Hu, Chunguang Yang, Ping Lei
224 [GO] 2021―Feb―18 The Promise of Aggregation-Induced Emission Luminogens for Detecting COVID-19 Zongwei Liu, Ting Meng, Xiaofang Tang, Ran Tian, Weijiang Guan
225 [GO] 2021―Feb―17 Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications Marinos C. Dalakas, Kleopatra Bitzogli, Harry Alexopoulos
226 [GO] 2021―Feb―13 Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19 Vincent J. Venditto, Dalia Haydar, Ahmed Abdel-Latif, John C. Gensel, Michael I. Anstead, Michelle G. Pitts, et al. (+4)
227 [GO] 2021―Feb―13 The Immunopathology of COVID-19 and the Cannabis Paradigm Nicole Paland, Antonina Pechkovsky, Miran Aswad, Haya Hamza, Tania Popov, Eduardo Shahar, Igal Louria-Hayon
228 [GO] 2021―Feb―08 Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19 Zhen Qin, Kefa Xiang, Ding-Feng Su, Yang Sun, Xia Liu
229 [GO] 2021―Feb―05 The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences Tayrine Ordonio Filgueira, Angela Castoldi, Lucas Eduardo R. Santos, Geraldo José de Amorim, Matheus Santos de Sousa Fernandes, Weydyson de Lima do Nascimento Anastácio, et al. (+3)
230 [GO] 2021―Feb―05 Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects Ching-Hsuan Liu, Cheng-Hua Lu, Shu Hui Wong, Liang-Tzung Lin
231 [GO] 2021―Feb―04 Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition K. de Joode, A. A. M. Oostvogels, C. H. GeurtsvanKessel, R. D. de Vries, R. H. J. Mathijssen, R. Debets, A. A. M. van der Veldt
232 [GO] 2021―Feb―03 Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19 Charles Ochieng’ Olwal, Nora Nghuchuzie Nganyewo, Kesego Tapela, Alexandra Lindsey Djomkam Zune, Oloche Owoicho, Yaw Bediako, Samuel Duodu
233 [GO] 2021―Feb―03 An Immunological Perspective: What Happened to Pregnant Women After Recovering From COVID-19? Sijia Zhao, Ting Xie, Li Shen, Hong Liu, Liling Wang, Xixiang Ma, et al. (+4)
234 [GO] 2021―Feb―02 Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients Ling Ni, Meng-Li Cheng, Yu Feng, Hui Zhao, Jingyuan Liu, Fang Ye, et al. (+13)
235 [GO] 2021―Jan―29 Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19 Xianfang Tang, Lijun Cai, Yajie Meng, JunLin Xu, Changcheng Lu, Jialiang Yang
236 [GO] 2021―Jan―29 Complement Activation in Kidneys of Patients With COVID-19 Frederick Pfister, Eva Vonbrunn, Tajana Ries, Hans-Martin Jäck, Klaus Überla, Günter Lochnit, et al. (+5)
237 [GO] 2021―Jan―29 High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19 Aiping Ma, Liang Zhang, Xiaokai Ye, Jing Chen, Jie Yu, Liangjin Zhuang, et al. (+4)
238 [GO] 2021―Jan―29 COVID-19: Imbalanced Immune Responses and Potential Immunotherapies Bing Xie, Jiancheng Zhang, Yuwen Li, Shiying Yuan, You Shang
239 [GO] 2021―Jan―29 COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes Thais Fernanda de Campos Fraga-Silva, Sandra Regina Maruyama, Carlos Arterio Sorgi, Elisa Maria de Sousa Russo, Ana Paula Morais Fernandes, Cristina Ribeiro de Barros Cardoso, et al. (+3)
240 [GO] 2021―Jan―29 Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System Edwin Estefan Reza-Zaldívar, Mercedes Azucena Hernández-Sapiéns, Benito Minjarez, Ulises Gómez-Pinedo, Ana Laura Márquez-Aguirre, Juan Carlos Mateos-Díaz, et al. (+2)
241 [GO] 2021―Jan―29 Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses Stephan Schlickeiser, Tatjana Schwarz, Sophie Steiner, Kirsten Wittke, Nabeel Al Besher, Oliver Meyer, et al. (+12)
242 [GO] 2021―Jan―28 Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals Savannah E. Butler, Andrew R. Crowley, Harini Natarajan, Shiwei Xu, Joshua A. Weiner, Carly A. Bobak, et al. (+6)
243 [GO] 2021―Jan―28 Key Components of Inflammasome and Pyroptosis Pathways Are Deficient in Canines and Felines, Possibly Affecting Their Response to SARS-CoV-2 Infection Haoran Cui, Leiliang Zhang
244 [GO] 2021―Jan―28 Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model Tingxuan Gu, Simin Zhao, Guoguo Jin, Mengqiu Song, Yafei Zhi, Ran Zhao, et al. (+10)
245 [GO] 2021―Jan―26 COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases Katja Lakota, Katja Perdan-Pirkmajer, Alojzija Hočevar, Snezna Sodin-Semrl, Žiga Rotar, Saša Čučnik, Polona Žigon
246 [GO] 2021―Jan―26 Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature Wilma Barcellini, Juri Alessandro Giannotta, Bruno Fattizzo
247 [GO] 2021―Jan―26 Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice Eva Fisher, Laura Padula, Kristin Podack, Katelyn O’Neill, Matthew M. Seavey, Padmini Jayaraman, et al. (+2)
248 [GO] 2021―Jan―25 Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm? Ramachandran Vignesh, Chinnambedu Ravichandran Swathirajan, Zaw Htet Tun, Marimuthu Ragavan Rameshkumar, Sunil Suhas Solomon, Pachamuthu Balakrishnan
249 [GO] 2021―Jan―22 Delving Into the Origin of Destructive Inflammation in COVID-19: A Betrayal of Natural Host Defense Peptides? Rebeca Garcia-Fandino, Ángel Piñeiro
250 [GO] 2021―Jan―22 Living in a Hostile World: Inflammation, New Drug Development, and Coronavirus Geoffrey P. Dobson, Erik Biros, Hayley L. Letson, Jodie L. Morris
251 [GO] 2021―Jan―20 Corrigendum: Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients Xuefeng Niu, Song Li, Pingchao Li, Wenjing Pan, Qian Wang, Ying Feng, et al. (+15)
252 [GO] 2021―Jan―20 Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences Jianfen Meng, Yuning Ma, Jinchao Jia, Mengyan Wang, Jialin Teng, Hui Shi, et al. (+18)
253 [GO] 2021―Jan―19 Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases Aristo Vojdani, Elroy Vojdani, Datis Kharrazian
254 [GO] 2021―Jan―14 Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel Nufar Marcus, Shirly Frizinsky, David Hagin, Adi Ovadia, Suhair Hanna, Michael Farkash, et al. (+17)
255 [GO] 2021―Jan―14 Does Angiotensin II Peak in Response to SARS-CoV-2? Léder Leal Xavier, Paula Fernanda Ribas Neves, Lisiê Valeria Paz, Laura Tartari Neves, Pamela Brambilla Bagatini, Luís Fernando Saraiva Macedo Timmers, et al. (+3)
256 [GO] 2021―Jan―14 Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2? Anastasia Polycarpou, Sofia Grigoriadou, Linda Klavinskis, Steven Sacks
257 [GO] 2021―Jan―10 Evolution Toward Severe Covid-19 From Biological Monitoring to Therapeutic Considerations Julien Carvelli, Audrey Le Saux, Jeremy Bourenne, Marc Gainnier, Gilles Kaplanski
258 [GO] 2021―Jan―10 Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures Jacob D. Galson, Sebastian Schaetzle, Rachael J. M. Bashford-Rogers, Matthew I. J. Raybould, Aleksandr Kovaltsuk, Gavin J. Kilpatrick, et al. (+15)
259 [GO] 2021―Jan―10 Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases Rita Carsetti, Salvatore Zaffina, Eva Piano Mortari, Sara Terreri, Francesco Corrente, Claudia Capponi, et al. (+24)
260 [GO] 2021―Jan―08 Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19 Rachel S. Cooper, Alasdair R. Fraser, Linda Smith, Paul Burgoyne, Stuart N. Imlach, Lisa M. Jarvis, et al. (+4)
261 [GO] 2021―Jan―08 HLA, Immune Response, and Susceptibility to COVID-19 Fataneh Tavasolian, Mohsen Rashidi, Gholam Reza Hatam, Marjan Jeddi, Ahmad Zavaran Hosseini, Sayed Hussain Mosawi, et al. (+2)
262 [GO] 2021―Jan―08 Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients Lili Li, Jie Li, Meiling Gao, Huimin Fan, Yanan Wang, Xin Xu, et al. (+11)
263 [GO] 2021―Jan―08 SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response Jackson S. Turner, Aaron Day, Wafaa B. Alsoussi, Zhuoming Liu, Jane A. O’Halloran, Rachel M. Presti, et al. (+4)
264 [GO] 2020―Dec―23 The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19 Jing Guo, He Xia, Shuting Wang, Liang Yu, Huafen Zhang, Jun Chen, et al. (+8)
265 [GO] 2020―Dec―23 COVID-19: Coronavirus Vaccine Development Updates Jing Zhao, Shan Zhao, Junxian Ou, Jing Zhang, Wendong Lan, Wenyi Guan, et al. (+6)
266 [GO] 2020―Dec―23 HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients Sophie Steiner, Franziska Sotzny, Sandra Bauer, Il-Kang Na, Michael Schmueck-Henneresse, Victor M. Corman, et al. (+7)
267 [GO] 2020―Dec―23 Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients’ Management Matthaios Speletas, Maria A. Kyritsi, Alexandros Vontas, Aikaterini Theodoridou, Theofilos Chrysanthidis, Sophia Hatzianastasiou, et al. (+2)
268 [GO] 2020―Dec―22 Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity Tugce Karaderi, Halin Bareke, Imge Kunter, Adil Seytanoglu, Ilgin Cagnan, Deniz Balci, et al. (+5)
269 [GO] 2020―Dec―22 RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics? Jonas B. Sandbrink, Robin J. Shattock
270 [GO] 2020―Dec―21 Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19 Anthony J. Leonardi, Rui B. Proenca
271 [GO] 2020―Dec―18 Class I HLA Allele Predicted Restricted Antigenic Coverages for Spike and Nucleocapsid Proteins Are Associated With Deaths Related to COVID-19 Marco Antônio M. Pretti, Rômulo G. Galvani, Gustavo Fioravanti Vieira, Adriana Bonomo, Martín H. Bonamino, Mariana Boroni
272 [GO] 2020―Dec―18 Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System Xiaorong Peng, Jing Ouyang, Stéphane Isnard, John Lin, Brandon Fombuena, Biao Zhu, Jean-Pierre Routy
273 [GO] 2020―Dec―18 NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients Ralf Kircheis, Emanuel Haasbach, Daniel Lueftenegger, Willm T. Heyken, Matthias Ocker, Oliver Planz
274 [GO] 2020―Dec―18 Humoral Responses and Serological Assays in SARS-CoV-2 Infections Yannick Galipeau, Matthew Greig, George Liu, Matt Driedger, Marc-André Langlois
275 [GO] 2020―Dec―18 A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters Anna C. Fagre, John Manhard, Rachel Adams, Miles Eckley, Shijun Zhan, Juliette Lewis, et al. (+13)
276 [GO] 2020―Dec―11 SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments Gisela Canedo-Marroquín, Farides Saavedra, Catalina A. Andrade, Roslye V. Berrios, Linmar Rodríguez-Guilarte, María C. Opazo, et al. (+2)
277 [GO] 2020―Dec―10 Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension Qiang Zeng, Yong-Zhe Li, Sheng-Yong Dong, Zong-Tao Chen, Xiang-Yang Gao, Han Zhang, et al. (+2)
278 [GO] 2020―Dec―09 Biomodulina T (InmunyVital®) Restores T Cells and Helps Contain COVID-19 Roman R. Rodriguez Martin, Olivia Gonzalez Gonzalez, Carolina Rodriguez Gonzalez, Rene R. Rodriguez Gonzalez
279 [GO] 2020―Dec―09 Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes Andrea Lombardi, Elena Trombetta, Alessandra Cattaneo, Valeria Castelli, Emanuele Palomba, Mario Tirone, et al. (+13)
280 [GO] 2020―Dec―09 A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection Firoz Ahmed
281 [GO] 2020―Dec―09 Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020) David S. Kim, Sarah Rowland-Jones, Ester Gea-Mallorquí
282 [GO] 2020―Dec―04 A Potential Bioelectromagnetic Method to Slow Down the Progression and Prevent the Development of Ultimate Pulmonary Fibrosis by COVID-19 Syed Muzzammil Masaud, Oliver Szasz, A. Marcell Szasz, Huma Ejaz, Rana Attique Anwar, Andras Szasz
283 [GO] 2020―Dec―04 Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience Roberto Littera, Marcello Campagna, Silvia Deidda, Goffredo Angioni, Selene Cipri, Maurizio Melis, et al. (+28)
284 [GO] 2020―Dec―03 B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients Víctor A. Sosa-Hernández, Jiram Torres-Ruíz, Rodrigo Cervantes-Díaz, Sandra Romero-Ramírez, José C. Páez-Franco, David E. Meza-Sánchez, et al. (+9)
285 [GO] 2020―Dec―01 Impact of Diabetes in Patients Diagnosed With COVID-19 Mohamed Abu-Farha, Fahd Al-Mulla, Thangavel Alphonse Thanaraj, Sina Kavalakatt, Hamad Ali, Mohammed Abdul Ghani, Jehad Abubaker
286 [GO] 2020―Dec―01 Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING? Jean-Marie Berthelot, Frédéric Lioté, Yves Maugars, Jean Sibilia
287 [GO] 2020―Nov―30 Controlling Cytokine Storm Is Vital in COVID-19 Lu Tang, Zhinan Yin, Yu Hu, Heng Mei
288 [GO] 2020―Nov―30 Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection Michael W. Russell, Zina Moldoveanu, Pearay L. Ogra, Jiri Mestecky
289 [GO] 2020―Nov―30 Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis Xijie Dong, Chuntao Wang, Xinghua Liu, Wei Gao, Xiangjun Bai, Zhanfei Li
290 [GO] 2020―Nov―26 Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset Juan Francisco Gutiérrez-Bautista, Antonio Rodriguez-Nicolas, Antonio Rosales-Castillo, Pilar Jiménez, Federico Garrido, Per Anderson, et al. (+2)
291 [GO] 2020―Nov―25 Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2 Xia Xiao, Conghui Wang, De Chang, Ying Wang, Xiaojing Dong, Tao Jiao, et al. (+6)
292 [GO] 2020―Nov―24 Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report Sabina Cenciarelli, Valeria Calbi, Federica Barzaghi, Maria Ester Bernardo, Chiara Oltolini, Maddalena Migliavacca, et al. (+26)
293 [GO] 2020―Nov―23 Pre-Existing Cytokine and NLRP3 Inflammasome Activation and Increased Vascular Permeability in Diabetes: A Possible Fatal Link With Worst COVID-19 Infection Outcomes? Vaia Lambadiari, Foteini Kousathana, Athanasios Raptis, Konstantinos Katogiannis, Alexander Kokkinos, Ignatios Ikonomidis
294 [GO] 2020―Nov―20 Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19 Karel F. A. Van Damme, Simon Tavernier, Nele Van Roy, Elisabeth De Leeuw, Jozefien Declercq, Cédric Bosteels, et al. (+14)
295 [GO] 2020―Nov―19 Analysis of Peripheral Blood IL-6 and Leukocyte Characteristics in 364 COVID-19 Patients of Wuhan Quan Li, Yuyu Xie, Zhangbo Cui, Shi Tang, Baodong Yuan, Hai Huang, et al. (+4)
296 [GO] 2020―Nov―18 MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity Miguel A. Vega, Miriam Simón-Fuentes, Arturo González de la Aleja, Concha Nieto, María Colmenares, Cristina Herrero, et al. (+2)
297 [GO] 2020―Nov―13 Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis Li Zhang, Binyang Zheng, Xingsu Gao, Libo Zhang, Hongxin Pan, Yong Qiao, et al. (+2)
298 [GO] 2020―Nov―09 Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art Yinhua Zhang, Yuanyuan Chen, Zhongji Meng
299 [GO] 2020―Nov―06 Adjuvants for Coronavirus Vaccines Zhihui Liang, Haoru Zhu, Xin Wang, Bo Jing, Zifan Li, Xinyu Xia, et al. (+6)
300 [GO] 2020―Nov―05 Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains Chloe H. Lee, Mariana Pereira Pinho, Paul R. Buckley, Isaac B. Woodhouse, Graham Ogg, Alison Simmons, et al. (+2)
301 [GO] 2020―Nov―02 Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus Isabel Kinney Ferreira De Miranda Santos, Carlos Henrique Nery Costa
302 [GO] 2020―Oct―30 NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19 Alberto López-Reyes, Carlos Martinez-Armenta, Rocio Espinosa-Velázquez, Paola Vázquez-Cárdenas, Marlid Cruz-Ramos, Berenice Palacios-Gonzalez, et al. (+2)
303 [GO] 2020―Oct―30 COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics Allison P. Spihlman, Nirupa Gadi, Samantha C. Wu, Vaishali R. Moulton
304 [GO] 2020―Oct―30 CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization Brien K. Haun, Chih-Yun Lai, Caitlin A. Williams, Teri Ann S. Wong, Michael M. Lieberman, Laurent Pessaint, et al. (+2)
305 [GO] 2020―Oct―28 The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19 Giuseppe Cerullo, Massimo Negro, Mauro Parimbelli, Michela Pecoraro, Simone Perna, Giorgio Liguori, et al. (+3)
306 [GO] 2020―Oct―28 I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People Anna Julia Pietrobon, Franciane Mouradian Emidio Teixeira, Maria Notomi Sato
307 [GO] 2020―Oct―28 Tea Bioactive Modulate Innate Immunity: In Perception to COVID-19 Pandemic Pritom Chowdhury, Anoop Kumar Barooah
308 [GO] 2020―Oct―28 Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets Sergio C. Oliveira, Mariana T. Q. de Magalhães, E. Jane Homan
309 [GO] 2020―Oct―27 A 21st Century Evil: Immunopathology and New Therapies of COVID-19 Taylon Felipe Silva, Fernanda Tomiotto-Pellissier, Raquel Arruda Sanfelice, Manoela Daiele Gonçalves, Bruna Taciane da Silva Bortoleti, Mariana Barbosa Detoni, et al. (+8)
310 [GO] 2020―Oct―27 Corrigendum: Interferon-α2b Treatment for COVID-19 Qiong Zhou, Virginia Chen, Casey P. Shannon, Xiao-Shan Wei, Xuan Xiang, Xu Wang, et al. (+4)
311 [GO] 2020―Oct―23 SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19 Howard M. Johnson, Alfred S. Lewin, Chulbul M. Ahmed
312 [GO] 2020―Oct―23 A Longitudinal Study of Immune Cells in Severe COVID-19 Patients Didier Payen, Maxime Cravat, Hadil Maadadi, Carole Didelot, Lydia Prosic, Claire Dupuis, et al. (+2)
313 [GO] 2020―Oct―22 Perspective: Reducing SARS-CoV2 Infectivity and Its Associated Immunopathology Abhishek Dubey, Surbhi Dahiya, Barry T. Rouse, Sharvan Sehrawat
314 [GO] 2020―Oct―21 COVID-19 as an Immune Complex Hypersensitivity in Antigen Excess Conditions: Theoretical Pathogenetic Process and Suggestions for Potential Therapeutic Interventions Giovanni Manzo
315 [GO] 2020―Oct―20 Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness Camilla Tincati, E. Stefania Cannizzo, Mauro Giacomelli, Raffaele Badolato, Antonella d’Arminio Monforte, Giulia Marchetti
316 [GO] 2020―Oct―16 Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines Pedro A. Reche
317 [GO] 2020―Oct―15 Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome Maria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, Daniele Curreli, Germana Cecchini, Caterina Bodio, et al. (+21)
318 [GO] 2020―Oct―15 Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis? Alberto Beretta, Martin Cranage, Donato Zipeto
319 [GO] 2020―Oct―14 A Review of the Progress and Challenges of Developing a Vaccine for COVID-19 Omna Sharma, Ali A. Sultan, Hong Ding, Chris R. Triggle
320 [GO] 2020―Oct―14 Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease Mingyue Li, Weina Guo, Yalan Dong, Xiaobei Wang, Die Dai, Xingxing Liu, et al. (+18)
321 [GO] 2020―Oct―14 The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation Chanan Meydan, Nimrod Madrer, Hermona Soreq
322 [GO] 2020―Oct―14 Coronavirus Proteins as Ion Channels: Current and Potential Research Conor McClenaghan, Alex Hanson, Sun-Joo Lee, Colin G. Nichols
323 [GO] 2020―Oct―12 A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds Lara Schöler, Vu Thuy Khanh Le-Trilling, Mareike Eilbrecht, Denise Mennerich, Olympia E. Anastasiou, Adalbert Krawczyk, et al. (+3)
324 [GO] 2020―Oct―08 The Inflammasome in Times of COVID-19 Juan Carlos de Rivero Vaccari, W. Dalton Dietrich, Robert W. Keane, Juan Pablo de Rivero Vaccari
325 [GO] 2020―Oct―08 T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis Bahire Kalfaoglu, José Almeida-Santos, Chanidapa Adele Tye, Yorifumi Satou, Masahiro Ono
326 [GO] 2020―Oct―08 COVID-19 Lethality in Sub-Saharan Africa and Helminth Immune Modulation Luis Fonte, Armando Acosta, Maria E. Sarmiento, María Ginori, Gissel García, Mohd Nor Norazmi
327 [GO] 2020―Oct―07 Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19 M. Mrityunjaya, V. Pavithra, R. Neelam, P. Janhavi, P. M. Halami, P. V. Ravindra
328 [GO] 2020―Oct―07 ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19 Donato Zipeto, Julys da Fonseca Palmeira, Gustavo A. Argañaraz, Enrique R. Argañaraz
329 [GO] 2020―Oct―07 The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens Liangwei Duan, Qianqian Zheng, Hongxia Zhang, Yuna Niu, Yunwei Lou, Hui Wang
330 [GO] 2020―Oct―06 Increased Plasma Heparanase Activity in COVID-19 Patients Baranca Buijsers, Cansu Yanginlar, Aline de Nooijer, Inge Grondman, Marissa L. Maciej-Hulme, Inge Jonkman, et al. (+13)
331 [GO] 2020―Oct―06 Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study Quirin Notz, Marc Schmalzing, Florian Wedekink, Tobias Schlesinger, Michael Gernert, Johannes Herrmann, et al. (+9)
332 [GO] 2020―Oct―06 Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19? Jon Hazeldine, Janet M. Lord
333 [GO] 2020―Oct―06 A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019 Ludovico De Stefano, Francesca Bobbio-Pallavicini, Antonio Manzo, Carlomaurizio Montecucco, Serena Bugatti
334 [GO] 2020―Oct―06 SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment Khalil Khalaf, Natalia Papp, Jadzia Tin-Tsen Chou, Doris Hana, Andrzej Mackiewicz, Mariusz Kaczmarek
335 [GO] 2020―Oct―02 Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD) Daniel Gagiannis, Julie Steinestel, Carsten Hackenbroch, Benno Schreiner, Michael Hannemann, Wilhelm Bloch, et al. (+6)
336 [GO] 2020―Oct―02 Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases Martina Ranzenigo, Claudia Pastori, Gabriel Siracusano, Elena Pariani, Caterina Uberti-Foppa, Lucia Lopalco
337 [GO] 2020―Oct―02 Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines Katie L. Flanagan, Emma Best, Nigel W. Crawford, Michelle Giles, Archana Koirala, Kristine Macartney, et al. (+3)
338 [GO] 2020―Sep―30 The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19 Gideon Schreiber
339 [GO] 2020―Sep―30 As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention Craig R. Travis
340 [GO] 2020―Sep―30 Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients Xuefeng Niu, Song Li, Pingchao Li, Wenjing Pan, Qian Wang, Ying Feng, et al. (+15)
341 [GO] 2020―Sep―30 Covid-19: Perspectives on Innate Immune Evasion Nima Taefehshokr, Sina Taefehshokr, Nima Hemmat, Bryan Heit
342 [GO] 2020―Sep―30 Is Herd Immunity Against SARS-CoV-2 a Silver Lining? Ramachandran Vignesh, Esaki M. Shankar, Vijayakumar Velu, Sadras Panchatcharam Thyagarajan
343 [GO] 2020―Sep―30 Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer Antonio Barbieri, Nirmal Robinson, Giuseppe Palma, Nicola Maurea, Vincenzo Desiderio, Gerardo Botti
344 [GO] 2020―Sep―29 Targeting Lipid Rafts-A Potential Therapy for COVID-19 Dmitri Sviridov, Yury I. Miller, Rami A. Ballout, Alan T. Remaley, Michael Bukrinsky
345 [GO] 2020―Sep―29 Immune Correlates of COVID-19 Control Bhawna Poonia, Shyam Kottilil
346 [GO] 2020―Sep―29 Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients Zhong-Jie Hu, Jia Xu, Ji-Ming Yin, Li Li, Wei Hou, Li-Li Zhang, et al. (+5)
347 [GO] 2020―Sep―29 Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial Salman Sadullah Usmani, Gajendra P. S. Raghava
348 [GO] 2020―Sep―28 An Effective COVID-19 Vaccine Needs to Engage T Cells Karsten Sauer, Tim Harris
349 [GO] 2020―Sep―25 Perspective: The Potential Effects of Naringenin in COVID-19 Ricardo Wesley Alberca, Franciane Mouradian Emidio Teixeira, Danielle Rosa Beserra, Emily Araujo de Oliveira, Milena Mary de Souza Andrade, Anna Julia Pietrobon, Maria Notomi Sato
350 [GO] 2020―Sep―25 Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS Ludmila Lupu, Annette Palmer, Markus Huber-Lang
351 [GO] 2020―Sep―24 COVID-19: In the Eye of the Cytokine Storm Roberto de la Rica, Marcio Borges, Marta Gonzalez-Freire
352 [GO] 2020―Sep―24 Airborne Particulate Matter and SARS-CoV-2 Partnership: Virus Hitchhiking, Stabilization and Immune Cell Targeting - A Hypothesis Z. Shadi Farhangrazi, Giulio Sancini, A. Christy Hunter, Seyed Moein Moghimi
353 [GO] 2020―Sep―23 Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology Jose Gómez-Rial, Maria José Currás-Tuala, Irene Rivero-Calle, Alberto Gómez-Carballa, Miriam Cebey-López, Carmen Rodríguez-Tenreiro, et al. (+7)
354 [GO] 2020―Sep―23 Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment Jing Ouyang, Stéphane Isnard, John Lin, Brandon Fombuena, Xiaorong Peng, Jean-Pierre Routy, Yaokai Chen
355 [GO] 2020―Sep―18 Cell-Free Therapies: Novel Approaches for COVID-19 Tatiana Maron-Gutierrez, Patricia R. M. Rocco
356 [GO] 2020―Sep―18 Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis Jarbas da Silva Motta Junior, Anna Flavia Ribeiro dos Santos Miggiolaro, Seigo Nagashima, Caroline Busatta Vaz de Paula, Cristina Pellegrino Baena, Julio Scharfstein, Lucia de Noronha
357 [GO] 2020―Sep―18 Familial Mediterranean Fever and COVID-19: Friends or Foes? Alessandro Stella, Mohamed Lamkanfi, Piero Portincasa
358 [GO] 2020―Sep―17 Immunopathogenesis of COVID-19: Summary and Possible Interventions Francois Henri Jacques, Erik Apedaile
359 [GO] 2020―Sep―17 Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective Indu Khatri, Frank J. T. Staal, Jacques J. M. van Dongen
360 [GO] 2020―Sep―15 Commentary: APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort Kyle Kasparian, David Graykowski, Eiron C�ck
361 [GO] 2020―Sep―11 COVID-19: Infection or Autoimmunity Timothy Icenogle
362 [GO] 2020―Sep―11 Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses Zeinab Abdelrahman, Mengyuan Li, Xiaosheng Wang
363 [GO] 2020―Sep―10 Neurological Damage by Coronaviruses: A Catastrophe in the Queue! Ritu Mishra, Akhil C. Banerjea
364 [GO] 2020―Sep―04 Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19 Wenxin Xu, Mingjie Wang, Demin Yu, Xinxin Zhang
365 [GO] 2020―Sep―04 Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and “New Old Friends” Thomas-Oliver Kleen, Alicia A. Galdon, Andrew S. MacDonald, Angus G. Dalgleish
366 [GO] 2020―Sep―03 Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country David Requena, Aldhair Médico, Ruy D. Chacón, Manuel Ramírez, Obert Marín-Sánchez
367 [GO] 2020―Sep―02 Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19 Sen Qun, Yulan Wang, Jun Chen, Xiang Huang, Hui Guo, Zhaohui Lu, et al. (+15)
368 [GO] 2020―Sep―02 Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease? Geoffrey Mark Verrall
369 [GO] 2020―Sep―02 Cytokine Storm in COVID-19: “When You Come Out of the Storm, You Won’t Be the Same Person Who Walked in” Vanessa Castelli, Annamaria Cimini, Claudio Ferri
370 [GO] 2020―Aug―28 Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19 Jang Hyun Park, Heung Kyu Lee
371 [GO] 2020―Aug―28 The Metabolic Changes and Immune Profiles in Patients With COVID-19 Bing He, Jun Wang, Yudie Wang, Juan Zhao, Juan Huang, Yu Tian, et al. (+6)
372 [GO] 2020―Aug―28 COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis Markus A. Schramm, Nils Venhoff, Dirk Wagner, Jens Thiel, Daniela Huzly, Nils Craig-Mueller, et al. (+4)
373 [GO] 2020―Aug―28 What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses Nirupa Gadi, Samantha C. Wu, Allison P. Spihlman, Vaishali R. Moulton
374 [GO] 2020―Aug―28 Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2 Inmaculada Sanclemente-Alaman, Lidia Moreno-Jiménez, María Soledad Benito-Martín, Alejandro Canales-Aguirre, Jordi A. Matías-Guiu, Jorge Matías-Guiu, Ulises Gómez-Pinedo
375 [GO] 2020―Aug―28 Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines Joana Vitte, Moïse Michel, Soraya Mezouar, Aïssatou Bailo Diallo, Asma Boumaza, Jean-Louis Mege, Benoit Desnues
376 [GO] 2020―Aug―26 The Immune Response and Immunopathology of COVID-19 Esmaeil Mortaz, Payam Tabarsi, Mohammad Varahram, Gert Folkerts, Ian M. Adcock
377 [GO] 2020―Aug―26 What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist Clarisa B. Palatnik-de-Sousa
378 [GO] 2020―Aug―26 Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease Marissa Herrmann, Sophia Schulte, Nils H. Wildner, Melanie Wittner, Thomas Theo Brehm, Michael Ramharter, et al. (+4)
379 [GO] 2020―Aug―25 Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome Massimo Caracciolo, Sebastiano Macheda, Demetrio Labate, Marco Tescione, Stefano La Scala, Eugenio Vadalà, et al. (+6)
380 [GO] 2020―Aug―21 PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19 Giuseppe Palma, Teresa Pasqua, Giovannino Silvestri, Carmine Rocca, Paola Gualtieri, Antonio Barbieri, et al. (+5)
381 [GO] 2020―Aug―19 The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development Sana O. Alturki, Sawsan O. Alturki, Jennifer Connors, Gina Cusimano, Michele A. Kutzler, Abdullah M. Izmirly, Elias K. Haddad
382 [GO] 2020―Aug―18 Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19 Jun Wang, Qian Li, Yongmei Yin, Yingying Zhang, Yingying Cao, Xiaoming Lin, et al. (+4)
383 [GO] 2020―Aug―18 Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider Juan Garcia-Revilla, Tomas Deierborg, Jose Luis Venero, Antonio Boza-Serrano
384 [GO] 2020―Aug―18 Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury Xianyang Chen, Huifang Guo, Li Qiu, Chengdong Zhang, Qiang Deng, Qibin Leng
385 [GO] 2020―Aug―18 Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections Hanaa Ahmed-Hassan, Brianna Sisson, Rajni Kant Shukla, Yasasvi Wijewantha, Nicholas T. Funderburg, Zihai Li, et al. (+3)
386 [GO] 2020―Aug―14 Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using in vitro Evolution and Reverse Genetics Hatem Zayed
387 [GO] 2020―Aug―14 Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System Pascal Urwyler, Stephan Moser, Panteleimon Charitos, Ingmar A. F. M. Heijnen, Melanie Rudin, Gregor Sommer, et al. (+5)
388 [GO] 2020―Aug―14 The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections Yun-yu Zhang, Bi-ru Li, Bo-tao Ning
389 [GO] 2020―Aug―13 Immunomodulatory Drugs in the Management of SARS-CoV-2 Daniel R. Burrage, Soraya Koushesh, Nidhi Sofat
390 [GO] 2020―Aug―11 The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19 Lauren A. Callender, Michelle Curran, Stephanie M. Bates, Maelle Mairesse, Julia Weigandt, Catherine J. Betts
391 [GO] 2020―Aug―11 Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key? Simone Meini, Andrea Zanichelli, Rodolfo Sbrojavacca, Federico Iuri, Anna Teresa Roberts, Chiara Suffritti, Carlo Tascini
392 [GO] 2020―Aug―11 Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection Anandita Pal, Kymberly M. Gowdy, Kenneth J. Oestreich, Melinda Beck, Saame Raza Shaikh
393 [GO] 2020―Aug―07 Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin? Chunfeng Li, Genhong Cheng
394 [GO] 2020―Aug―07 Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response Lucas Leite Cunha, Sandro Felix Perazzio, Jamil Azzi, Paolo Cravedi, Leonardo Vidal Riella
395 [GO] 2020―Aug―07 Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies Xuemin Guo, Lizhu Zeng, Zhen Huang, Yongjun He, Zhuojin Zhang, Zhixiong Zhong
396 [GO] 2020―Aug―07 Combating COVID-19: MVA Vector Vaccines Applied to the Respiratory Tract as Promising Approach Toward Protective Immunity in the Lung Reinhold Förster, Henrike Fleige, Gerd Sutter
397 [GO] 2020―Aug―07 Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, Dipyaman Ganguly, Samit Chattopadhyay
398 [GO] 2020―Aug―04 Mucosal-Associated Invariant T Cells as a Possible Target to Suppress Secondary Infections at COVID-19 Roman A. Akasov, Evgeny V. Khaydukov
399 [GO] 2020―Aug―04 Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus Isabel Kinney Ferreira de Miranda Santos, Carlos Henrique Nery Costa
400 [GO] 2020―Jul―28 Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches Rong Dong, Zhugang Chu, Fuxun Yu, Yan Zha
401 [GO] 2020―Jul―28 Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19? Samir Jawhara
402 [GO] 2020―Jul―21 Mechanisms Underlying Potential Therapeutic Approaches for COVID-19 Abdelouaheb Benani, Sanae Ben Mkaddem
403 [GO] 2020―Jul―21 The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies Lea Skak Filtenborg Frederiksen, Yibang Zhang, Camilla Foged, Aneesh Thakur
404 [GO] 2020―Jul―21 COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella Geoffroy Méry, Olivier Epaulard, Anne-Laure Borel, Bertrand Toussaint, Audrey Le Gouellec
405 [GO] 2020―Jul―14 Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19? Anne Geller, Jun Yan
406 [GO] 2020―Jul―14 Prevention of Severe Coronavirus Disease 2019 Outcomes by Reducing Low-Grade Inflammation in High-Risk Categories Radu Tudor Ciornei
407 [GO] 2020―Jul―10 Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach Anam Naz, Fatima Shahid, Tariq Tahir Butt, Faryal Mehwish Awan, Amjad Ali, Arif Malik
408 [GO] 2020―Jul―10 A Hypothesis for the Possible Role of Zinc in the Immunological Pathways Related to COVID-19 Infection Ander Mayor-Ibarguren, Carmen Busca-Arenzana, Ángel Robles-Marhuenda
409 [GO] 2020―Jul―10 The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis Inga Wessels, Benjamin Rolles, Lothar Rink
410 [GO] 2020―Jul―10 Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper Sonu Bhaskar, Akansha Sinha, Maciej Banach, Shikha Mittoo, Robert Weissert, Joseph S. Kass, et al. (+3)
411 [GO] 2020―Jul―10 Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies Yujun Tang, Jiajia Liu, Dingyi Zhang, Zhenghao Xu, Jinjun Ji, Chengping Wen
412 [GO] 2020―Jul―10 The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions Anahid Jewett
413 [GO] 2020―Jul―10 Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach Shweta Choudhary, Yashpal S. Malik, Shailly Tomar
414 [GO] 2020―Jul―09 Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements Kosagi-Sharaf Rao, Vaddi Suryaprakash, Rajappa Senthilkumar, Senthilkumar Preethy, Shojiro Katoh, Nobunao Ikewaki, Samuel J. K. Abraham
415 [GO] 2020―Jul―07 Pregnancy, Viral Infection, and COVID-19 Ricardo Wesley Alberca, Nátalli Zanete Pereira, Luanda Mara Da Silva Oliveira, Sarah Cristina Gozzi-Silva, Maria Notomi Sato
416 [GO] 2020―Jul―07 Potential Fast COVID-19 Containment With Trehalose Daisy Martinon, Vanessa F. Borges, Angela C. Gomez, Kenichi Shimada
417 [GO] 2020―Jul―07 Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option Philip F. Stahel, Scott R. Barnum
418 [GO] 2020―Jul―03 Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19 Adam Klocperk, Zuzana Parackova, Jitka Dissou, Hana Malcova, Petr Pavlicek, Tomas Vymazal, et al. (+2)
419 [GO] 2020―Jul―03 Establishing a Unified COVID-19 “Immunome”: Integrating Coronavirus Pathogenesis and Host Immunopathology Els Wauters, Karin Thevissen, Carine Wouters, Francesca Maria Bosisio, Frederik De Smet, Jan Gunst, et al. (+10)
420 [GO] 2020―Jul―03 COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning Edison Ong, Mei U Wong, Anthony Huffman, Yongqun He
421 [GO] 2020―Jul―03 Cell-Mediated Immune Responses to COVID-19 Infection Amélie Guihot, Elena Litvinova, Brigitte Autran, Patrice Debré, Vincent Vieillard
422 [GO] 2020―Jul―03 Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies Aldo Bonaventura, Alessandra Vecchié, Tisha S. Wang, Elinor Lee, Paul C. Cremer, Brenna Carey, et al. (+6)
423 [GO] 2020―Jul―03 Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment Felipe Saldanha-Araujo, Emãnuella Melgaço Garcez, Amandda Evelin Silva-Carvalho, Juliana Lott Carvalho
424 [GO] 2020―Jun―30 Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19 Madalina Elena Carter-Timofte, Sofie Eg Jørgensen, Mette Ratzer Freytag, Michelle Mølgaard Thomsen, Nanna-Sophie Brinck Andersen, Ali Al-Mousawi, et al. (+2)
425 [GO] 2020―Jun―26 Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19 Rafael B. Polidoro, Robert S. Hagan, Roberta de Santis Santiago, Nathan W. Schmidt
426 [GO] 2020―Jun―26 Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse Luiz G. Gardinassi, Camila O. S. Souza, Helioswilton Sales-Campos, Simone G. Fonseca
427 [GO] 2020―Jun―26 Severe COVID-19: NLRP3 Inflammasome Dysregulated Daan F. van den Berg, Anje A. te Velde
428 [GO] 2020―Jun―23 Targeting the NLRP3 Inflammasome in Severe COVID-19 Tracey L. Freeman, Talia H. Swartz
429 [GO] 2020―Jun―23 Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies Marisa Market, Leonard Angka, Andre B. Martel, Donald Bastin, Oladunni Olanubi, Gayashan Tennakoon, et al. (+4)
430 [GO] 2020―Jun―23 Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation? Daniela Morniroli, Maria Lorella Giannì, Alessandra Consales, Carlo Pietrasanta, Fabio Mosca
431 [GO] 2020―Jun―23 Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients Serena Colafrancesco, Rossana Scrivo, Cristiana Barbati, Fabrizio Conti, Roberta Priori
432 [GO] 2020―Jun―23 Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2 Rocktotpal Konwarh
433 [GO] 2020―Jun―23 Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics? John F. Arboleda, Silvio Urcuqui-Inchima
434 [GO] 2020―Jun―19 Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19) Ruben Manuel Luciano Colunga Biancatelli, Max Berrill, John D. Catravas, Paul E. Marik
435 [GO] 2020―Jun―19 Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis Adonis Sfera, Carolina Osorio, Nyla Jafri, Eddie Lee Diaz, Jose E. Campo Maldonado
436 [GO] 2020―Jun―18 Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection? Martina Severa, Cinthia Farina, Marco Salvetti, Eliana Marina Coccia
437 [GO] 2020―Jun―16 Immune Response, Inflammation, and the Clinical Spectrum of COVID-19 Luis F. García
438 [GO] 2020―Jun―16 The COVID-19 Cytokine Storm; What We Know So Far Dina Ragab, Haitham Salah Eldin, Mohamed Taeimah, Rasha Khattab, Ramy Salem
439 [GO] 2020―Jun―16 Solid Organ Transplantation During the COVID-19 Pandemic Hedong Zhang, Helong Dai, Xubiao Xie
440 [GO] 2020―Jun―16 Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids Yi Miao, Lei Fan, Jian-Yong Li
441 [GO] 2020―Jun―11 Activation of TRL-7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy Konstantinos Poulas, Konstantinos Farsalinos, Charilaos Zanidis
442 [GO] 2020―Jun―11 Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm Jesus Gonzalez-Rubio, Carmen Navarro-Lopez, Elena Lopez-Najera, Ana Lopez-Najera, Lydia Jimenez-Diaz, Juan D. Navarro-Lopez, Alberto Najera
443 [GO] 2020―Jun―10 Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells Mahmood Yaseen Hachim, Saba Al Heialy, Ibrahim Yaseen Hachim, Rabih Halwani, Abiola C. Senok, Azzam A. Maghazachi, Qutayba Hamid
444 [GO] 2020―Jun―05 Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline Muhammad Abbas Abid, Loren Nunley, Muhammad Bilal Abid
445 [GO] 2020―Jun―05 The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe? Zaid Abassi, Yara Knaney, Tony Karram, Samuel N. Heyman
446 [GO] 2020―May―29 COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase Scott B. Halstead, Ramesh Akkina
447 [GO] 2020―May―29 Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation Marco Cardone, Masahide Yano, Amy S. Rosenberg, Montserrat Puig
448 [GO] 2020―May―28 Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate? Luciano Mutti, Francesca Pentimalli, Giovanni Baglio, Patrizia Maiorano, Rita Emilena Saladino, Pierpaolo Correale, Antonio Giordano
449 [GO] 2020―May―28 Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm Piero Ruscitti, Onorina Berardicurti, Paola Di Benedetto, Paola Cipriani, Annamaria Iagnocco, Yehuda Shoenfeld, Roberto Giacomelli
450 [GO] 2020―May―28 Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection? Harald Murck
451 [GO] 2020―May―28 Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing? Athar Khalil, Amina Kamar, Georges Nemer
452 [GO] 2020―May―28 Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets? Jean-Michel Sallenave, Loïc Guillot
453 [GO] 2020―May―27 Could SARS-CoV-2-Induced Hyperinflammation Magnify the Severity of Coronavirus Disease (CoViD-19) Leading to Acute Respiratory Distress Syndrome? A. S. Smiline Girija, Esaki M. Shankar, Marie Larsson
454 [GO] 2020―May―27 Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health Ícaro Raony, Camila Saggioro de Figueiredo, Pablo Pandolfo, Elizabeth Giestal-de-Araujo, Priscilla Oliveira-Silva Bomfim, Wilson Savino
455 [GO] 2020―May―27 Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs Stefania Scala, Roberto Pacelli
456 [GO] 2020―May―19 Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19 Adnan Shah
457 [GO] 2020―May―19 MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy Guido Moll, Norman Drzeniek, Julian Kamhieh-Milz, Sven Geissler, Hans-Dieter Volk, Petra Reinke
458 [GO] 2020―May―15 Interferon-α2b Treatment for COVID-19 Qiong Zhou, Virginia Chen, Casey P. Shannon, Xiao-Shan Wei, Xuan Xiang, Xu Wang, et al. (+4)
459 [GO] 2020―May―15 Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy? Farha Naz, Mohd Arish
460 [GO] 2020―May―15 Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art Gabriel Siracusano, Claudia Pastori, Lucia Lopalco
461 [GO] 2020―May―12 Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS Nora Möhn, Refik Pul, Christoph Kleinschnitz, Harald Prüss, Torsten Witte, Martin Stangel, Thomas Skripuletz
462 [GO] 2020―May―12 Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection Yanwen Liang, Mong-Lien Wang, Chian-Shiu Chien, Aliaksandr A. Yarmishyn, Yi-Ping Yang, Wei-Yi Lai, et al. (+5)
463 [GO] 2020―May―08 Pangolins Lack IFIH1/MDA5, a Cytoplasmic RNA Sensor That Initiates Innate Immune Defense Upon Coronavirus Infection Heinz Fischer, Erwin Tschachler, Leopold Eckhart
464 [GO] 2020―May―08 Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2? Camila Covián, Angello Retamal-Díaz, Susan M. Bueno, Alexis M. Kalergis
465 [GO] 2020―May―07 Coronavirus Disease (COVID-19-SARS-CoV-2) and Nutrition: Is Infection in Italy Suggesting a Connection? Hellas Cena, Marcello Chieppa
466 [GO] 2020―May―01 Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) Bo Diao, Chenhui Wang, Yingjun Tan, Xiewan Chen, Ying Liu, Lifen Ning, et al. (+9)
467 [GO] 2020―Apr―30 Potential SARS-CoV-2 Preimmune IgM Epitopes Velizar Shivarov, Peter K. Petrov, Anastas D. Pashov
468 [GO] 2020―Apr―24 Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control Cheryl Yi-Pin Lee, Raymond T. P. Lin, Laurent Renia, Lisa F. P. Ng
469 [GO] 2020―Apr―21 Commentary: Origin and evolution of pathogenic coronaviruses Shun Adachi, Takaaki Koma, Naoya Doi, Masako Nomaguchi, Akio Adachi


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.136 sec